300 ML immune globulin intravenous (human) - ifas 100 MG/ML Injection [Panzyga]
immune
RxCUI: 2102472
What the CMS Formulary Data Shows for 300 ML immune globulin intravenous (human) - ifas 100 MG/ML Injection [Panzyga]
Per the CMS 2026 Part D formulary file, 300 ML immune globulin intravenous (human) - ifas 100 MG/ML Injection [Panzyga] (RxNorm concept RXCUI 2102472, generic name immune) appears on 65 distinct formulary files spanning 741 Medicare Part D plan offerings - 14.6% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 6, with a cross-plan average of Tier 4.2.
Real-world access to 300 ML immune globulin intravenous (human) - ifas 100 MG/ML Injection [Panzyga] depends on utilization management as much as tier placement: 100% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 219 Part D beneficiaries filled 300 ML immune globulin intravenous (human) - ifas 100 MG/ML Injection [Panzyga] in 2023, with total plan-and-beneficiary spending of $34,429,902 and an average per-beneficiary annual cost of $157,214.17. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry 300 ML immune globulin intravenous (human) - ifas 100 MG/ML Injection [Panzyga] today.
Coverage Details
- Formularies covering
- 65
- Plans covering
- 741
- Coverage rate
- 14.6%
- Tier range
- Tier 1 – Tier 6
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 100% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 219
- Total spending
- $34,429,902
- Avg per beneficiary
- $157,214.17
Tier Distribution Across Plans
Standalone Drug Plans (PDP) Covering 300 ML immune globulin intravenous (human) - ifas 100 MG/ML Injection [Panzyga]
9 standalone prescription drug plans include this drug.
| Plan | Insurer | Tier | PA | ST | Premium | States |
|---|---|---|---|---|---|---|
| HealthSpring Assurance Rx (PDP) | MEDCO CONTAINMENT LIFE AND MEDCO CONTAINMENT NY | T5 | Yes | No | $0 | - |
| HealthSpring Assurance Rx (PDP) | MEDCO CONTAINMENT LIFE AND MEDCO CONTAINMENT NY | T5 | Yes | No | $0 | - |
| HealthSpring Assurance Rx (PDP) | MEDCO CONTAINMENT LIFE AND MEDCO CONTAINMENT NY | T5 | Yes | No | $0 | - |
| HealthSpring Assurance Rx (PDP) | MEDCO CONTAINMENT LIFE AND MEDCO CONTAINMENT NY | T5 | Yes | No | $0 | - |
| HealthSpring Assurance Rx (PDP) | MEDCO CONTAINMENT LIFE AND MEDCO CONTAINMENT NY | T5 | Yes | No | $0 | - |
| HealthSpring Assurance Rx (PDP) | MEDCO CONTAINMENT LIFE AND MEDCO CONTAINMENT NY | T5 | Yes | No | $0 | - |
| HealthSpring Assurance Rx (PDP) | MEDCO CONTAINMENT LIFE AND MEDCO CONTAINMENT NY | T5 | Yes | No | $0 | - |
| HealthSpring Assurance Rx (PDP) | MEDCO CONTAINMENT LIFE AND MEDCO CONTAINMENT NY | T5 | Yes | No | $0 | - |
| HealthSpring Assurance Rx (PDP) | MEDCO CONTAINMENT LIFE AND MEDCO CONTAINMENT NY | T5 | Yes | No | $0 | - |
Medicare Advantage Plans (MA-PD) Covering 300 ML immune globulin intravenous (human) - ifas 100 MG/ML Injection [Panzyga]
91 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Florida Complete Care-Duals VIP (HMO-POS D-SNP) | HPMP OF FLORIDA, INC. | T1 | Yes | $0 | FL |
| Mercy Care Advantage (HMO D-SNP) | MERCY CARE | T1 | Yes | $0 | AZ |
| Mercy Care Advantage (HMO D-SNP) | MERCY CARE | T1 | Yes | $0 | AZ |
| Mercy Care Advantage (HMO D-SNP) | MERCY CARE | T1 | Yes | $0 | AZ |
| Elderplan Plus Long-Term Care (HMO-POS D-SNP) | ELDERPLAN, INC. | T1 | Yes | $0 | NY |
| Health Choice Pathway (HMO D-SNP) | HEALTH CHOICE ARIZONA, INC. | T1 | Yes | $0 | AZ |
| Healthfirst CompleteCare (HMO D-SNP) | HEALTHFIRST HEALTH PLAN, INC. | T1 | Yes | $0 | NY |
| IMCare Classic (HMO D-SNP) | ITASCA MEDICAL CARE | T1 | Yes | $0 | MN |
| Johns Hopkins Advantage MD D-SNP (HMO D-SNP) | HOPKINS HEALTH ADVANTAGE, INC. | T1 | Yes | $0 | MD |
| MetroPlus UltraCare (HMO D-SNP) | METROPLUS HEALTH PLAN, INC. | T1 | Yes | $0 | NY |
| Senior Whole Health SCO (HMO D-SNP) | SENIOR WHOLE HEALTH, LLC | T1 | Yes | $0 | MA |
| Senior Whole Health SCO NHC (HMO D-SNP) | SENIOR WHOLE HEALTH, LLC | T1 | Yes | $0 | MA |
| Molina One Care (HMO D-SNP) | SENIOR WHOLE HEALTH, LLC | T1 | Yes | $0 | MA |
| CCA One Care (HMO D-SNP) | COMMONWEALTH CARE ALLIANCE, INC. | T1 | Yes | $0 | MA |
| CCA Senior Care Options (HMO D-SNP) | COMMONWEALTH CARE ALLIANCE, INC. | T1 | Yes | $0 | MA |
| Mass General Brigham SCO (HMO D-SNP) | MASS GENERAL BRIGHAM HEALTH PLAN, INC | T1 | Yes | $0 | MA |
| Mass General Brigham One Care (HMO D-SNP) | MASS GENERAL BRIGHAM HEALTH PLAN, INC | T1 | Yes | $0 | MA |
| Florida Complete Care (HMO I-SNP) | HPMP OF FLORIDA, INC. | T1 | Yes | $4.80 | FL |
| Florida Complete Care- In The Community (HMO-POS I-SNP) | HPMP OF FLORIDA, INC. | T1 | Yes | $4.80 | FL |
| Elderplan For Medicaid Beneficiaries (HMO-POS D-SNP) | ELDERPLAN, INC. | T1 | Yes | $22.70 | NY |
| VIVA Medicare Extra Value (HMO D-SNP) | VIVA HEALTH, INC. | T1 | Yes | $27.70 | AL |
| VIVA Medicare Extra Care (HMO D-SNP) | VIVA HEALTH, INC. | T1 | Yes | $27.70 | AL |
| Elderplan Advantage For Nursing Home Residents (HMO-POS I-SNP) | ELDERPLAN, INC. | T1 | Yes | $44.80 | NY |
| MetroPlus Platinum Plan (HMO) | METROPLUS HEALTH PLAN, INC. | T1 | Yes | $58.80 | NY |
| CalOptima Health OneCare Complete (HMO D-SNP) | ORANGE COUNTY HEALTH AUTHORITY | T2 | Yes | $0 | CA |
| BlueCare Plus (HMO D-SNP) | VOLUNTEER STATE HEALTH PLAN | T4 | Yes | $0 | TN |
| BlueCare Plus Choice (HMO D-SNP) | VOLUNTEER STATE HEALTH PLAN | T4 | Yes | $0 | TN |
| BlueCare Plus Select (HMO D-SNP) | VOLUNTEER STATE HEALTH PLAN | T4 | Yes | $0 | TN |
| Sharp Direct Advantage Gold (HMO) | SHARP HEALTH PLAN | T5 | Yes | $0 | CA |
| Sharp Direct Advantage VIP (HMO) | SHARP HEALTH PLAN | T5 | Yes | $0 | CA |
| Sharp Direct Advantage VIP Plus (HMO) | SHARP HEALTH PLAN | T5 | Yes | $0 | CA |
| Blue Medicare Advantage PPO (PPO) | WELLMARK ADVANTAGE HEALTH PLAN, INC. | T5 | Yes | $0 | IA |
| BlueMedicare Premier (HMO) | USABLE HMO, INC. | T5 | Yes | $0 | AR |
| BlueMedicare Classic Plus (HMO) | USABLE HMO, INC. | T5 | Yes | $0 | AR |
| Medicare HMO Blue SaverRx (HMO-POS) | BCBS OF MASSACHUSETTS HMO BLUE, INC. | T5 | Yes | $0 | MA |
| Clever Care Longevity (HMO) | CLEVER CARE OF GOLDEN STATE, INC. | T5 | Yes | $0 | CA |
| Clever Care Value (HMO) | CLEVER CARE OF GOLDEN STATE, INC. | T5 | Yes | $0 | CA |
| Clever Care Total+ (HMO C-SNP) | CLEVER CARE OF GOLDEN STATE, INC. | T5 | Yes | $0 | CA |
| Clever Care Breathe+ (HMO C-SNP) | CLEVER CARE OF GOLDEN STATE, INC. | T5 | Yes | $0 | CA |
| Clover Health Choice (PPO) | CLOVER INSURANCE COMPANY | T5 | Yes | $0 | TX |
| Clover Health LiveHealthy (PPO) | CLOVER INSURANCE COMPANY | T5 | Yes | $0 | GA |
| Clover Health LiveHealthy (PPO) | CLOVER INSURANCE COMPANY | T5 | Yes | $0 | SC |
| Clover Health Choice (PPO) | CLOVER INSURANCE COMPANY | T5 | Yes | $0 | PA |
| Clover Health LiveHealthy Giveback (PPO) | CLOVER INSURANCE COMPANY | T5 | Yes | $0 | GA, SC |
| Clover Health Choice (PPO) | CLOVER INSURANCE COMPANY | T5 | Yes | $0 | NJ |
| Clover Health Choice (PPO) | CLOVER INSURANCE COMPANY | T5 | Yes | $0 | NJ |
| Clover Health Choice Giveback (PPO) | CLOVER INSURANCE COMPANY | T5 | Yes | $0 | NJ |
| Clover Health Classic (HMO) | CLOVER HMO OF NEW JERSEY INC. | T5 | Yes | $0 | NJ |
| Elderplan Flex (HMO-POS) | ELDERPLAN, INC. | T5 | Yes | $0 | NY |
| Elderplan Select (HMO-POS I-SNP) | ELDERPLAN, INC. | T5 | Yes | $0 | NY |
Frequently Asked Questions
Is 300 ML immune globulin intravenous (human) - ifas 100 MG/ML Injection [Panzyga] covered by Medicare Part D?
Yes, 300 ML immune globulin intravenous (human) - ifas 100 MG/ML Injection [Panzyga] is covered by 741 Medicare Part D plans (14.6% of all Part D formularies).
What tier is 300 ML immune globulin intravenous (human) - ifas 100 MG/ML Injection [Panzyga] on Medicare Part D plans?
300 ML immune globulin intravenous (human) - ifas 100 MG/ML Injection [Panzyga] averages Tier 4.2 across Part D plans, ranging from Tier 1 to Tier 6.
Does 300 ML immune globulin intravenous (human) - ifas 100 MG/ML Injection [Panzyga] require prior authorization?
100% of Part D formularies require prior authorization for 300 ML immune globulin intravenous (human) - ifas 100 MG/ML Injection [Panzyga]. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on 300 ML immune globulin intravenous (human) - ifas 100 MG/ML Injection [Panzyga]?
In 2023, total Medicare Part D spending on 300 ML immune globulin intravenous (human) - ifas 100 MG/ML Injection [Panzyga] was $34,429,902, covering 219 beneficiaries. The average spend per beneficiary was $157,214.17.
Read our methodology - how this data is sourced, computed, and verified.